United States · Health Care · USD · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Sector average (own scale)
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for NANOVIRICIDES, INC.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
| ROE | -116.87% | -240.06% | 171.37% | 63.39% | 40.15% | 28.79% |
| Sector average | 73.17% | 65.88% | 68.36% | 41.61% | 44.34% | 12.47% |
| ROA | -101.26% | -111.76% | -133.65% | -134.38% | -140.25% | -141.05% |
| Total Assets | $9,873,614.00 | $7,079,504.00 | $7,079,504.00 | $7,079,504.00 | $7,079,504.00 | $7,079,504.00 |
| Sector average | $3,537,396,325.28 | $3,954,880,656.28 | $4,602,556,361.88 | |||
| Net Income | -$9,466,966.00 | -$9,473,236.67 | -$9,461,508.08 | -$9,513,703.65 | -$9,929,333.85 | -$9,985,452.79 |
| Valuation | $35,755,214.60 | $35,778,897.94 | $35,734,600.90 | $35,931,735.21 | $37,501,503.94 | $37,713,456.19 |
| Stock Price | $1.40 | $1.40 | $1.40 | $1.41 | $1.47 | $1.48 |
| $5,424,035,314.63 |
| $6,260,073,835.74 |
| $9,342,681,178.44 |